Schumer and Democratic Senator Joe Manchin recently introduced the Inflation Reduction Act, which aims to assist people in saving money on pharmaceutical drugs and health premiums, which should boost demand.
On the other hand, the pharmaceutical industry is transforming with the emergence of new technologies and better efficiency. The fast-advancing field of personalized medicines is further creating opportunities for long-term growth. Manufacturers have been redesigning their supply chain to better align with the patient-centric models.
